LENZ Therapeutics EPS LENZ

Diluted earnings per share by quarter and over the last twelve months, from 2020.

LENZ Therapeutics' earnings per share was −$4.09 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.02.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.02	n/a	−$4.09
Q1 FY26	Mar 31, 2026	−$1.32	n/a	−$3.60
Q4 FY25	Dec 31, 2025	−$1.16	n/a	−$2.81
Q3 FY25	Sep 30, 2025	−$0.59	n/a	−$2.11
Q2 FY25	Jun 30, 2025	−$0.53	n/a	−$1.90
Q1 FY25	Mar 31, 2025	−$0.53	n/a	−$1.77
Q4 FY24	Dec 31, 2024	−$0.46	n/a	−$4.77
Q3 FY24	Sep 30, 2024	−$0.38	n/a	−$16.35
Q2 FY24	Jun 30, 2024	−$0.40	n/a	−$25.59
Q1 FY24	Mar 31, 2024	−$3.53	n/a	−$32.72
Q4 FY23	Dec 31, 2023	−$12.04	n/a	−$35.69
Q3 FY23	Sep 30, 2023	−$9.62	n/a	−$26.73

Companies in Healthcare nearest LENZ Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
LENZLENZ Therapeutics	−$4.09
KEQUKewaunee Scientific	$2.76	−33% a year
ICCCImmucell	$0.08	−58% a year
LFVNLifevantage	$0.40	−46% a year
SPROSpero Therapeutics	$0.11
APTAlpha Pro Tech	$0.41	+24% a year
PDEXPro DEX	$4.11	+52% a year
PLXProtalix BioTherapeutics	$0.23	+283% a year
ATNMActinium Pharmaceuticals	$0.36
NATRNatures Sunshine Products	$1.01	+36% a year
ELMDElectromed	$1.31	+56% a year
Peer median	$0.41